English
Back
Download
Log in to access Online Inquiry
Back to the Top
avatar
Teddy123 commented on a stock · May 14 19:02

BioCryst Announces FDA Acceptance of NDA for ORLADEYO® (berotralstat) Oral Granules in Patients with Hereditary Angioedema Aged 2 to 11 Years

BioCryst Announces FDA Acceptance of NDA for ORLADEYO® (berotralstat) Oral Granules in Patients with Hereditary Angioedema Aged 2 to 11 Years
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
10K Views
Comment
Sign in to post a comment
    avatar
    Teddy123
    Just exploring the app to grow my money. Don't scold me if I'm copying u k 😂
    899
    Followers
    47
    Following
    3527
    Visitors
    Follow

    Market Insights

    Inverse ETF Inverse ETF
    No. Symbol Turnover
    Sample Name
    Sample Code
     1.40B
    Sample Name
    Sample Code
     901.54M
    Sample Name
    Sample Code
     496.62M
    4
    ProShares UltraPro Short S&P500 ETF
    SPXU
    407.37M
    5
    Proshares Ultrashort S&P500
    SDS
    301.19M
    Unlock Now

    Tariff Flames: Trump's Global Economic Gambit

    How Trump's Tariffs Shake Markets

    Discussing

    Gold has rebounded to $3,300! It's time to get on board?
    🎙️ Discussion: 1. Has it $Gold Futures (AUG5) (GCmain.US)$ rebounded to $3,300? Will the short-term trend continue to rise? 2. What factors Show More
    S&P 500's Put/Call Ratio Hits 5-Year Low: Fear Fades and Bottom Near?

    Monetary Policy: Navigating the Fed's Rate Cut Cycle

    Changing Fed policy is altering the market math for investors.

    Earnings Season Underway

    Earnings season is here. What to know?

    - No more -